July 11-July 15: Who said What in Biotech and Pharmaceutical Industries?


Check out myriad promises that researchers and scientists made regarding their innovation and research and the collaborators filled us with the hope to take their business to a higher level and benefit the human race;


Quote 1.

WHO’s prequalification of the Alere HIV Combo reflects our commitment to making high-quality point-of-care HIV diagnostics available in areas with the greatest burden of HIV infection”Who said it? Answer is here

Quote 2.

We are pleased to join with Boehringer Ingelheim to study the potential of their molecule in combination with Lilly’s abemaciclib, for which we have an active Phase 3 development programme underway,”– Who said it? Answer is here

Quote 3.

It appears very likely that each round of treatment stimulates the bone marrow to churn out freshly activated monocytes, which distribute throughout the body, spare normal cells, and find and kill cancer cells.” -Who said it? Answer is here

Quote 4.

We are extremely pleased to work with Seres, a leader in the development of microbiome therapeutics, and apply our Organs-on-Chips technology to enhance drug discovery in an emerging field, such as the microbiome,” -Who said it? Answer is here

Quote 5.

This is potentially one of the most important clinical findings in the pharmacologic treatment of postpartum depression to date.” -Who said it? Answer is here

Quote 6.

These data speak for themselves. Given the societal impact of this condition, and the possible identification of a biological basis for treating these women, we are hopeful these data will point to a new understanding of this disorder and the development of effective therapies-Who said it? Answer is here

Quote 7.

The clinical program supporting the approval of Xiidra is the largest for an investigational-stage dry eye disease candidate to date, including more than 2,500 patientsWho said it? Answer is here

Quote 8.

 “Repatha is the only PCSK9 inhibitor with an approved monthly dose, and now the only one with a monthly single-dose administration. The FDA approval of the Pushtronex system offers another delivery option to patients who need the additional LDL cholesterol lowering that Repatha can provide.”-Who said it? Answer is here

Quote 9.

There are plenty of people who are not happy with existing cochlear implants-Who said it? Answer is here

Quote 10.

Launch of InfuSMART will help us remain a meaningful player in the global oncology therapy market by offering differentiating cancer treatment solutions. We believe there are opportunities for us to expand our portfolio of ready-to-administer products across multiple therapies where time and safety are an important element of treatment.Who said it? Answer is here

Quote 11.

Advancing SER-262 to the clinic is a landmark event for Seres and the microbiome field in general. The SER-262 program has demonstrated our ability to rapidly develop a new class of synthetic microbiome therapeutics comprised of rationally designed bacterial compositions,” -Who said it? Answer is here

Leave a reply

Your email address will not be published. Required fields are marked *